Invesco Ltd. boosted its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 39.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 218,795 shares of the company's stock after purchasing an additional 61,678 shares during the period. Invesco Ltd. owned about 0.48% of Azenta worth $10,940,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Picton Mahoney Asset Management increased its holdings in Azenta by 305.7% during the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after purchasing an additional 532 shares during the period. Headlands Technologies LLC purchased a new stake in Azenta in the fourth quarter worth about $40,000. KBC Group NV grew its holdings in Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after acquiring an additional 698 shares in the last quarter. Assenagon Asset Management S.A. purchased a new position in Azenta during the 4th quarter valued at about $200,000. Finally, Landscape Capital Management L.L.C. bought a new stake in shares of Azenta in the 4th quarter valued at about $217,000. 99.08% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
AZTA has been the subject of a number of recent analyst reports. Needham & Company LLC raised their price objective on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research report on Thursday, February 6th. Stephens restated an "overweight" rating and set a $60.00 price objective on shares of Azenta in a report on Thursday, January 2nd. Evercore ISI lifted their target price on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research note on Thursday, February 6th. Finally, TD Cowen raised shares of Azenta to a "hold" rating in a report on Thursday, February 27th.
Read Our Latest Research Report on AZTA
Azenta Stock Up 1.1 %
Shares of NASDAQ:AZTA traded up $0.29 during midday trading on Monday, reaching $27.02. The company's stock had a trading volume of 718,045 shares, compared to its average volume of 648,288. The stock has a fifty day moving average of $34.66 and a 200 day moving average of $43.11. Azenta, Inc. has a twelve month low of $24.06 and a twelve month high of $63.58. The firm has a market capitalization of $1.23 billion, a PE ratio of -9.07 and a beta of 1.66.
Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Sell-side analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.
About Azenta
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Recommended Stories

Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.